文献速递呼吸道感染呼吸危重症与机械通气

重症COVID-19患者的医院获得性感染特征与结局

Hospital-Acquired Infections in Critically Ill Patients With COVID-19.
PubMed 文献 · Chest · 2021-04-20

这项多中心回顾性研究纳入意大利8家医院774例重症COVID-19成人患者,46%发生医院获得性感染(HAI),以呼吸机相关肺炎和血流感染为主,35%为多重耐药菌。HAI延长机械通气和住院时间,合并感染性休克时死亡率近乎翻倍。

要点

  • 重症COVID-19患者HAI发生率高,以VAP和BSI为主,多重耐药菌占35%。
  • HAI显著延长机械通气、ICU和总住院时间。
  • HAI合并感染性休克时死亡率近乎翻倍,非复杂性感染不影响死亡率。

核心结论

  • 重症COVID-19患者医院获得性感染风险高,尤其是多重耐药菌所致的VAP和BSI。
  • HAI延长机械通气和住院时间,合并感染性休克时死亡率近乎翻倍。

研究设计与样本

  • 多中心回顾性分析,前瞻性收集意大利8家枢纽医院2020年2月20日至5月20日收治的774例重症COVID-19成人患者数据。

主要发现

  • 359例(46%)患者发生759次HAI,密度为44.7次/1000 ICU患者日,35%为多重耐药菌。
  • VAP 389例(50%),血流感染183例(34%),导管相关血流感染74例(10%)。
  • VAP密度26.0/1000插管日(95%CI 23.6-28.8),BSI密度11.7/1000 ICU患者日(95%CI 10.1-13.5),导管相关BSI密度4.7/1000 ICU患者日(95%CI 3.8-5.9)。
  • VAP中革兰阴性菌(尤其肠杆菌目)占64%,金黄色葡萄球菌占28%。
  • 与感染独立相关的变量包括年龄、呼气末正压和入院时使用广谱抗生素。

临床怎么用

  • 对重症COVID-19患者应高度警惕HAI,尤其VAP和BSI,并关注多重耐药菌风险。
  • 加强感染防控和抗菌药物管理,以减少HAI及其对机械通气和住院时间的影响。
  • HAI合并感染性休克提示预后不良,需积极识别和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few small studies have described hospital-acquired infections (HAIs) occurring in patients with COVID-19. RESEARCH QUESTION: What characteristics in critically ill patients with COVID-19 are associated with HAIs and how are HAIs associated with outcomes in these patients? STUDY DESIGN AND METHODS: Multicenter retrospective analysis of prospectively collected data including adult patients with severe COVID-19 admitted to eight Italian hub hospitals from February 20, 2020, through May 20, 2020. Descriptive statistics and univariate and multivariate Weibull regression models were used to assess incidence, microbial cause, resistance patterns, risk factors (ie, demographics, comorbidities, exposure to medication), and impact on outcomes (ie, ICU discharge, length of ICU and hospital stays, and duration of mechanical ventilation) of microbiologically confirmed HAIs. RESULTS: Of the 774 included patients, 359 patients (46%) demonstrated 759 HAIs (44.7 infections/1,000 ICU patient-days; 35% multidrug-resistant [MDR] bacteria). Ventilator-associated pneumonia (VAP; n = 389 [50%]), bloodstream infections (BSIs; n = 183 [34%]), and catheter-related BSIs (n = 74 [10%]) were the most frequent HAIs, with 26.0 (95% CI, 23.6-28.8) VAPs per 1,000 intubation-days, 11.7 (95% CI, 10.1-13.5) BSIs per 1,000 ICU patient-days, and 4.7 (95% CI, 3.8-5.9) catheter-related BSIs per 1,000 ICU patient-days. Gram-negative bacteria (especially Enterobacterales) and Staphylococcus aureus caused 64% and 28% of cases of VAP, respectively. Variables independently associated with infection were age, positive end expiratory pressure, and treatment with broad-spectrum antibiotics at admission. Two hundred thirty-four patients (30%) died in the ICU (15.3 deaths/1,000 ICU patient-days). Patients with HAIs complicated by septic shock showed an almost doubled mortality rate (52% vs 29%), whereas noncomplicated infections did not affect mortality. HAIs prolonged mechanical ventilation (median, 24 days [interquartile range (IQR), 14-39 days] vs 9 days [IQR, 5-13 days]; P < .001), ICU stay (24 days [IQR, 16-41 days] vs 9 days [IQR, 6-14 days]; P = .003), and hospital stay (42 days [IQR, 25-59 days] vs 23 days [IQR, 13-34 days]; P < .001). INTERPRETATION: Critically ill patients with COVID-19 are at high risk for HAIs, especially VAPs and BSIs resulting from MDR organisms. HAIs prolong mechanical ventilation and hospitalization, and HAIs complicated by septic shock almost double mortality. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT04388670; URL: www.clinicaltrials.gov.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Grasselli G, Scaravilli V, Mangioni D, et al. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021. PMID: 33857475. doi:10.1016/j.chest.2021.04.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。